The Role of Biotin in Bacterial Physiology and Virulence: a Novel Antibiotic Target for Mycobacterium tuberculosis

Author:

Salaemae Wanisa1,Booker Grant W.12,Polyak Steven W.12

Affiliation:

1. Department of Molecular and Cellular Biology, School of Biological Science, The University of Adelaide, North Terrace Campus, Adelaide, South Australia 5005, Australia

2. Center for Molecular Pathology, University of Adelaide, North Terrace Campus, Adelaide, South Australia 5005, Australia

Abstract

ABSTRACT Biotin is an essential cofactor for enzymes present in key metabolic pathways such as fatty acid biosynthesis, replenishment of the tricarboxylic acid cycle, and amino acid metabolism. Biotin is synthesized de novo in microorganisms, plants, and fungi, but this metabolic activity is absent in mammals, making biotin biosynthesis an attractive target for antibiotic discovery. In particular, biotin biosynthesis plays important metabolic roles as the sole source of biotin in all stages of the Mycobacterium tuberculosis life cycle due to the lack of a transporter for scavenging exogenous biotin. Biotin is intimately associated with lipid synthesis where the products form key components of the mycobacterial cell membrane that are critical for bacterial survival and pathogenesis. In this review we discuss the central role of biotin in bacterial physiology and highlight studies that demonstrate the importance of its biosynthesis for virulence. The structural biology of the known biotin synthetic enzymes is described alongside studies using structure-guided design, phenotypic screening, and fragment-based approaches to drug discovery as routes to new antituberculosis agents.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference173 articles.

1. World Health Organization. 2014. WHO Fact Sheet No 104. http://www.who.int/mediacentre/factsheets/fs104/en/.

2. World Health Organization. 2006. The Global Plan to Stop TB 2006-2015 . Part I Strategic directions. WHO Geneva Switzerland.

3. World Health Organization. 2012. “Totally drug-resistant” tuberculosis: a WHO consultation on the diagnostic definition and treatment options. http://www.who.int/tb/challenges/xdr/xdrconsultation/en/.

4. World Health Organization. 2015. Global Tuberculosis Report 2014 . WHO Geneva Switzerland.

5. Demissie M Lemma E Gebeyehu M Lindtjorn B. 2001. Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa. Scan J Infec Dis 33: 914–919. [CrossRef]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3